KRAUSE JAMES 4
4 · NEUROGEN CORP · Filed May 25, 2004
Insider Transaction Report
Form 4
NEUROGEN CORPNRGN
KRAUSE JAMES
Senior VP Biology
Transactions
- Award
Stock Option (Right to Buy)
2004-05-21+50,000→ 0 totalExercise: $9.50From: 2005-05-21→ Common Stock .025 Par Value Per Share (50,000 underlying)
Footnotes (1)
- [F1]On 05/21/2004 the reporting person was granted an option to purchase 50,000 shares pursuant to the Issuer's Amended and Restated 2001 Neurogen Stock Option Plan. The options vest in 4 equal annual installments and expire 5 years from each vesting date.